Year: 2022

NIH – HEAL Initiative: Research Studies to Develop and Implement Interventions to Prevent Opioid Misuse in Community Health Centers (R61/R33 Clinical Trial Required)

8/5/2022

Purpose: This funding opportunity announcement (FOA) is part of the Helping to End Addiction Long-term (HEAL) Prevention Initiative, a portfolio of research focused on the prevention of opioid misuse and…

NIH: Type 1 Diabetes Mellitus Stakeholder Engagement Innovation Center to Advance Health Equity (U2C Clinical Trial Not Allowed)

7/29/2022

Purpose: This U2C funding opportunity announcement (FOA) is a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) initiative to establish a novel national Stakeholder Engagement Innovation Center for…

HEAL Initiative: Coordinated Pain Care in Health Care Systems Research Program – Coordinating Center (U24 Clinical Trial Not Allowed)

7/29/2022

Purpose: The purpose of this FOA is to solicit applications for a Coordinating Center to provide leadership for the HEAL Coordinated Approaches to Pain Care in Health Care Systems Program.…

ARVO Foundation: Kreissig Award for Excellence in Retinal Surgery

7/29/2022

Purpose: This award, established by Ingrid Kreissig, MD in 2020 with an endowment through the ARVO Foundation, recognizes the next generation of curious, enterprising investigators who seek to optimize functional…

Melanoma Research Alliance

7/22/2022

Purpose: The Melanoma Research Alliance (MRA) is pleased to announce a Special Opportunity Request for Proposals (RFP) for Team Science Awards focused on patient-centric clinical trials, jointly funded by The Rising…

NIH – Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes (T1D) Research (U01 Clinical Trial Not Allowed)

7/22/2022

Purpose: This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing the development and/or validation of targeted mass spectrometric assays (e.g. Multiple Reaction Monitoring) for proteins and peptides of primary…

NIH – HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 – Clinical Trials Optional)

7/22/2022

Purpose: Through the HEAL Initiative, NIH requests applications for studies designed to develop and test sustainable, scalable interventions to prevent opioid misuse, opioid use disorder, and co-occurring mental health conditions…

NIH – Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed)

7/22/2022

Purpose: This Funding Opportunity Announcement invites multiple Program Director/Principal Investigator (multi-PD/PI) applications to conduct a study to establish a longitudinal cohort of individuals who developed diabetes following SARS-CoV-2 infection to…

NIH – HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 – Clinical Trial Optional)

7/15/2022

Purpose: Specifically, NIDA seeks applications for multi-project RM1 Opioid Use Disorder Quality Measurement and Management Research Centers (OUD-QM2RCs). OUD-QM2RCs will involve researchers and a partner with a deployed or in-development…

NIH – Regenerative Medicine Innovation Projects (RMIP) Investigator- Initiated Studies (Collaborative U01 – Clinical Trial Not Allowed)

7/15/2022

Purpose: The National Institutes of Health (NIH) participating Institutes and Centers, in coordination with the U.S. Food and Drug Administration, invite cooperative agreement (U01) applications to support investigator-initiated clinical research…